RESUMO
Enterovirus D68 (EV-D68) infections are associated with severe respiratory disease and acute flaccid myelitis (AFM). The European Non-Polio Enterovirus Network (ENPEN) aimed to investigate the epidemiological and genetic characteristics of EV-D68 and its clinical impact during the fall-winter season of 2021/22. From 19 European countries, 58 institutes reported 10,481 (6.8%) EV-positive samples of which 1,004 (9.6%) were identified as EV-D68 (852 respiratory samples). Clinical data was reported for 969 cases. 78.9% of infections were reported in children (0-5 years); 37.9% of cases were hospitalised. Acute respiratory distress was commonly noted (93.1%) followed by fever (49.4%). Neurological problems were observed in 6.4% of cases with six reported with AFM. Phylodynamic/Nextstrain and phylogenetic analyses based on 694 sequences showed the emergence of two novel B3-derived lineages, with no regional clustering. In conclusion, we describe a large-scale EV-D68 European upsurge with severe clinical impact and the emergence of B3-derived lineages.
RESUMO
PURPOSE: To evaluate the rates of amenorrhea and menstrual irregularities in patients with active thyroid eye disease treated with teprotumumab. METHODS: A retrospective review was conducted of patients with active thyroid eye disease treated between 2020 and 2022 at a single institution. Female thyroid eye disease patients with regular menstruation at baseline who completed 8 infusions of teprotumumab were assessed. Patient-reported irregularities in menstruation or amenorrhea were recorded during routine clinic visits. Two sample t tests were used to assess differences between patients endorsing and denying menstrual irregularities. RESULTS: Twelve patients met the inclusion criteria. The mean age was 38.33 ± 9.6 years (range 25-53 years). The average follow-up after treatment completion was 11.43 months. Nine patients (75%) reported changes from their baseline menstruation. Four patients (33.3%) reported irregularities during treatment only. Three patients (25%) had persistence of irregularities after treatment; these patients regained normal cycles at an average of 3 months following teprotumumab completion. Two patients (16.7%) did not regain their normal cycles at the time of their last follow-up. One 53-year-old patient-reported persistent amenorrhea after treatment completion. One patient-reported menorrhagia at a 4-month follow-up. No significant age difference was found between patients with or without reported menstrual changes ( p = 0.43). CONCLUSION: Abnormalities of menstruation, including amenorrhea, were reported by 75% of patients treated with teprotumumab. These changes reverted to baseline after treatment in most affected patients.
Assuntos
Amenorreia , Anticorpos Monoclonais Humanizados , Oftalmopatia de Graves , Humanos , Feminino , Pessoa de Meia-Idade , Adulto , Estudos Retrospectivos , Amenorreia/induzido quimicamente , Oftalmopatia de Graves/tratamento farmacológico , Oftalmopatia de Graves/complicações , Oftalmopatia de Graves/diagnóstico , Anticorpos Monoclonais Humanizados/uso terapêutico , Anticorpos Monoclonais Humanizados/efeitos adversos , Distúrbios Menstruais/tratamento farmacológicoRESUMO
Two patients had persistent compressive dysthyroid optic neuropathy after decompression of the medial orbital wall and floor. In both cases, there was ~3 mm of unresected lamina papyracea anterior to the Annulus of Zinn, and removal of this residual bone led to resolution of the neuropathy. These illustrative cases suggest that, in some patients, even small amounts of residual crowding at the orbital apex can critically embarrass optic nerve perfusion, with resulting continued ischemic optic neuropathy.
Assuntos
Oftalmopatia de Graves , Doenças do Nervo Óptico , Humanos , Oftalmopatia de Graves/cirurgia , Descompressão Cirúrgica/métodos , Órbita/cirurgia , Doenças do Nervo Óptico/etiologia , Nervo Óptico/cirurgia , Estudos RetrospectivosRESUMO
Congenital orbital fibrosis (COF) is a rare disorder characterized by an infiltrating orbital mass with secondary involvement of the extraocular muscles that may present with extraocular muscle dysfunction, and globe and eyelid abnormalities in infancy. This condition is thought to be a nonprogressive process and literature on longitudinal assessment of COF is limited. The authors describe a case of COF which was followed for 15 years. The patient had stable symptoms of ocular dysmotility and ptosis but was noted to have spontaneous regression of the orbital mass on serial MRI.
Assuntos
Blefaroptose , Doenças Palpebrais , Doenças Orbitárias , Neoplasias Orbitárias , Humanos , Neoplasias Orbitárias/patologia , Músculos Oculomotores/patologia , Doenças Palpebrais/diagnóstico , Blefaroptose/diagnóstico , Blefaroptose/etiologia , Blefaroptose/patologia , Doenças Orbitárias/patologia , FibroseRESUMO
BackgroundOrbital cysts associated with microphthalmia are colobomatous lesions that typically present unilaterally and posterior to the globe. Case Report: A male infant had an orbital cyst associated with microphthalmia located anterior to the globe composed of a neuroglial wall, ependymal-like epithelial lining, with synaptophysin-positive cells resembling the retinal neuronal layer. Conclusion: This orbital cyst may represent a malformation of the eye rather than an encephalocele.
Assuntos
Coloboma , Cistos , Microftalmia , Doenças Orbitárias , Coloboma/complicações , Coloboma/patologia , Cistos/patologia , Encefalocele , Humanos , Lactente , Masculino , Microftalmia/complicações , Microftalmia/patologia , Doenças Orbitárias/complicações , Doenças Orbitárias/diagnóstico , Doenças Orbitárias/patologiaRESUMO
ABSTRACT: Idiopathic intracranial hypertension (IIH) is a syndrome associated with increased intracranial pressure without a clear underlying cause that is classically seen in young women. Patients typically present with headache and ocular findings, including disc edema and, less frequently, an abduction deficit. To make a diagnosis of IIH, other than cranial nerve 6 or 7 dysfunction, patients must have a normal neurologic examination. When cranial nerve 7 is affected patients can present with hemifacial spasm. We present the case of a young woman with IIH who had hemifacial spasm as one of the presenting symptoms. Her symptoms resolved once she was treated for IIH with acetazolamide.
Assuntos
Doenças do Nervo Facial/complicações , Espasmo Hemifacial/etiologia , Pressão Intracraniana/fisiologia , Pseudotumor Cerebral/complicações , Adulto , Doenças do Nervo Facial/diagnóstico , Feminino , Espasmo Hemifacial/diagnóstico , Humanos , Imageamento por Ressonância Magnética , Pseudotumor Cerebral/diagnóstico , Pseudotumor Cerebral/fisiopatologiaRESUMO
OBJECTIVES: Behavioural and psychological symptoms (BPS) worsen quality of life and increase institutionalization in dementia, but the relationship between BPS and vascular burden on neuroimaging is unclear. Our aim is to explore whether the profile of BPS differs between patients with large-vessel or cortical vascular dementia (cVaD), small-vessel or subcortical vascular dementia (sVaD) and Alzheimer's disease (AD). METHODS: The BEVASDE study comprised 806 demented patients (cVaD-136, sVaD-184, AD-486) recruited from outpatient consultations in Salamanca and Avila, Spain. The Clinical Dementia Rating Scale (CDR) and the 12-item Neuropsychiatric Inventory (NPI) were used to evaluate dementia severity and BPS. RESULTS: BPS were reported in 98.5%, 97.3% and 96.9% of the cVaD, sVaD and AD cases, respectively. The median NPI score was 36 in both cVaD and sVaD and 34 in AD, with a median number of four symptoms per patient. The most frequent disorders were depression (64.4%), apathy (61.8%) and sleep disturbance (60.5%). Multivariate regression analyses after controlling for possible confounders showed a higher risk of euphoria (p = 0.011), apathy (p = 0.007), irritability (p = 0.002) and sleep disturbance (p = 0.020) in cVaD than in AD and more apathy (p = 0.0001) and irritability (p = 0.0001) in sVaD than in AD. In contrast, AD subjects had a higher risk of delusions (p = 0.007) and hallucinations (p = 0.023) than patients with cVaD as well as more aberrant motor behaviour than both cVaD (p = 0.0001) and sVaD (p = 0.003). CONCLUSION: BPS are common in dementia and may help in differential diagnosis of the various subtypes. We should inquire about them and treat as necessary.
Assuntos
Efeitos Psicossociais da Doença , Demência Vascular/diagnóstico por imagem , Demência Vascular/psicologia , Testes Neuropsicológicos , Idoso , Idoso de 80 Anos ou mais , Demência Vascular/sangue , Feminino , Humanos , Estudos ProspectivosRESUMO
In this work, 260 pesticide residues, including insecticides, acaricides, fungicides, and herbicides, were extracted from honeybees using the QuEChERS methodology modified by applying an ultrasonic probe, which avoided the homogenization step and reduced the extraction time. Gas and liquid chromatography, both coupled to triple-quadrupole mass spectrometry, allowed the determination of the pesticide residues extracted from the samples. The optimization of the main ultrasonic conditions (sonication amplitude, number of cycles, and time of each cycle) was performed using a Box-Behnken experimental design involving 15 experimental samples. The results obtained with this approach showed that the recoveries were not affected by these experimental parameters for 95 pesticide residues whereas the sonication amplitude was the main factor affecting the recoveries of 107 pesticide residues. The extraction time and the number of cycles affected four and one pesticide residues, respectively. The effectiveness of the ultrasonic-assisted extraction without homogenization of the honeybee samples compared favorably with that for the conventional QuEChERS methodology applied to the same previously homogenized samples. The proposed methodology was validated according to the SANTE/11945/2015 guidelines, with a 5 µg/kg limit of quantitation. Recoveries between 70 and 120% and relative standard deviations lower than 20% were obtained for most analytes. Thirty honeybee samples taken from Spanish apiaries were analyzed using this new methodology. The results revealed the presence of 30 different pesticide residues in the honeybee samples, the highest concentration levels corresponding to certain insecticides/acaricides used by beekeepers to control Varroa destructor. Permethrin, thiabendazole, carbendazim, and coumaphos were the most frequently detected pesticide residues in the selected samples.
Assuntos
Abelhas/química , Cromatografia Gasosa-Espectrometria de Massas/métodos , Resíduos de Praguicidas/análise , Sonicação/métodos , Espectrometria de Massas em Tandem/métodos , Animais , Cromatografia Líquida/métodos , Limite de Detecção , Resíduos de Praguicidas/isolamento & purificaçãoAssuntos
Encefalite Japonesa/complicações , Febre Amarela/complicações , Angola , Coinfecção , Vírus da Encefalite Japonesa (Espécie)/genética , Vírus da Encefalite Japonesa (Espécie)/isolamento & purificação , Humanos , Masculino , Filogenia , RNA Viral/análise , Vírus da Febre Amarela/genética , Vírus da Febre Amarela/isolamento & purificação , Adulto JovemRESUMO
BACKGROUND: Osteopathia striata combined with cranial sclerosis (OS-CS) is an inherited skeletal dysplasia that manifests with macrocephaly, orofacial abnormalities, thickened craniofacial bones, and vertically oriented radiodensities of the long bones. CASE REPORT: Here, we present a severe case of OS-CS in a 4-year-old girl causing optic neuropathy as shown by radiographic evidence, ophthalmic findings, and histopathology. Previous genetic testing in this patient revealed a de novo heterozygous mutation in AMER1 (c.1057C>T, p.Arg353Ter). Although the patient had a pre-existing, appropriately functioning, ventriculoperitoneal (VP) shunt, a subsequent MRI of the brain and orbits showed narrowing of the bilateral optic nerve canals secondary to osseous thickening causing bilateral optic nerve atrophy, worse on the left. The patient underwent staged bilateral orbital osteotomies, optic canal decompression, and bilateral frontal craniotomy, and at 11 months postoperatively, her vision remained stable. Conclusions: While up to 50% of the patients with OS-CS may experience hearing loss due to cranial nerve compression, we present a case of severe visual loss secondary to OS-CS-associated optic nerve compression.
Assuntos
Doenças do Nervo Óptico , Osteocondrodisplasias , Osteosclerose , Feminino , Humanos , Pré-Escolar , Osteosclerose/complicações , Osteosclerose/genética , Doenças do Nervo Óptico/diagnóstico , Doenças do Nervo Óptico/etiologia , Nervo ÓpticoRESUMO
Noroviruses are among the most important causes of acute gastroenteritis (AGE). In summer 2021, a large outbreak of norovirus infections affecting 163 patients, including 15 norovirus-confirmed food handlers, occurred in a hotel in Murcia in southeast Spain. A rare GI.5[P4] norovirus strain was identified as the cause of the outbreak. The epidemiological investigation determined that norovirus transmission might have been initiated through an infected food handler. The food safety inspection found that some symptomatic food handlers continued working during illness. Molecular investigation with whole-genome and ORF1 sequencing provided enhanced genetic discrimination over ORF2 sequencing alone and enabled differentiation of the GI.5[P4] strains into separate subclusters, suggesting different chains of transmission. These recombinant viruses have been identified circulating globally over the last 5 years, warranting further global surveillance. IMPORTANCE Due to the large genetic diversity of noroviruses, it is important to enhance the discriminatory power of typing techniques to differentiate strains when investigating outbreaks and elucidating transmission chains. This study highlights the importance of (i) using whole-genome sequencing to ensure genetic differentiation of GI noroviruses to track chains of transmission during outbreak investigations and (ii) the adherence of symptomatic food handlers to work exclusion rules and strict hand hygiene practices. To our knowledge, this study provides the first full-length genome sequences of GI.5[P4] strains apart from the prototype strain.
RESUMO
Most of the studies differentiating the effect of size-classified particulate matter (PM) exposure have been carried out in cities where the average levels of fine particles (PM(2.5)) were higher than those of coarse particles (PM(10-2.5)). These studies have suggested that PM(2.5) is associated with daily mortality, but there is only limited evidence that PM(10-2.5) is independently associated with mortality. The citizens of the Canary Islands are exposed to PM which is highly influenced by mineral dust because of the islands' proximity to the Western Coast of Morocco. This offers an excellent opportunity to analyze in detail the short-term association between PM size fractions and total, respiratory and heart disease mortality. A time-series study from 2001 to 2004 was carried out. For each PM size fraction and mortality outcome, Generalized Additive Poisson Model was performed controlling for potential confounding. Different lag structures, unconstrained distributed lag models and two-pollutant models were examined. After assessing the linearity in the relationship, a piecewise linear analysis for exploring the existence of different slopes for different ranges of PM was carried out. The 10 µg/m(3) increase in PM(2.5) and PM(10-2.5) levels was associated with a 7.5% (95% confidence interval=0.4-15.0) and a 7.4 (95% CI=1.5-13.7) increase in heart and respiratory disease mortality, respectively. Spline curves were quite linear over the PM concentrations seen on most days (dominated by combustion sources) in these cities, meanwhile on days with higher particulate levels (natural sources) a risk increase above certain PM levels was found, suggesting a curvilinear association and that, at least in some locations, PM(10-2.5) can play an important role in PM-related toxicity. The overall findings suggest that the establishment of new air quality standards for the short-term effect of PM(2.5) and PM(10-2.5) and further limiting levels of PM(10) in European Union is advisable.
Assuntos
Poluentes Atmosféricos/análise , Mortalidade/tendências , Material Particulado/análise , Poluentes Atmosféricos/toxicidade , Monitoramento Ambiental , Monitoramento Epidemiológico , Cardiopatias/mortalidade , Humanos , Modelos Teóricos , Tamanho da Partícula , Material Particulado/toxicidade , Distribuição de Poisson , Doenças Respiratórias/mortalidade , Medição de Risco , Espanha/epidemiologiaRESUMO
PURPOSE: To examine the risk, prevalence, and progression of glaucoma development in age-related macular degeneration (AMD) eyes receiving intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections compared to controls. DESIGN: Retrospective clinical cohort study. METHODS: Retrospective review of eyes receiving intravitreal anti-VEGF injections from January 1, 2004, to December 31, 2013, for exudative AMD. Age- and sex-matched control groups of eyes included eyes with nonexudative AMD (NEAMD) and no AMD. Eyes with a diagnosis of glaucoma or glaucoma suspect were reviewed for injection details, type and date of glaucoma diagnosis, glaucoma treatments, standard automated perimetry (SAP), and spectral domain optical coherence tomography (SD-OCT). Qualitative progression was determined by indication of glaucoma progression in provider notes. Quantitative progression was assessed based on change in mean deviation (MD) on SAP, retinal nerve fiber layer thickness on SD-OCT, and intraocular pressure (IOP). RESULTS: There were 707 eyes of 504 patients treated with anti-VEGF injections and 1008 eyes in the NEAMD and no-AMD cohorts. There was no difference in glaucoma or suspect prevalence at initial presentation between eyes treated with injections and NEAMD (6.9% vs 9.7%, P = .22) or no-AMD controls (vs 8.5%, P = .55). There was no difference in cumulative 5-year probability of new glaucoma diagnosis after anti-VEGF injections compared to NEAMD (1.9% vs 1.0%, P = .69) or no-AMD controls (vs 1.6%, P = .88). There was no difference in qualitative progression of glaucoma in the injection cohort vs NEAMD (P = .19) or no-AMD controls (P = .61). The rate of MD change in injection eyes was similar to NEAMD eyes (P = .74) but greater than no-AMD eyes (P = .02). Eyes receiving injections required more topical glaucoma medications compared with NEAMD (P = .03) and more glaucoma laser treatments compared with no-AMD controls (P = .009). Eyes receiving injections did not require more frequent incisional glaucoma surgery compared with NEAMD (21.0% vs 15.0%, P = .95) or no-AMD controls (vs 10.0%, P = .10). CONCLUSION: Eyes treated with intravitreal anti-VEGF injections for exudative AMD did not have increased risk of developing glaucoma compared with controls. Of those with a glaucoma diagnosis, exudative AMD eyes receiving injections required a greater number of topical glaucoma medications compared with NEAMD eyes and had a greater rate of MD loss than no-AMD controls.
Assuntos
Glaucoma , Degeneração Macular , Degeneração Macular Exsudativa , Humanos , Fatores de Crescimento Endotelial , Estudos Retrospectivos , Prevalência , Estudos de Coortes , Inibidores da Angiogênese/uso terapêutico , Fator A de Crescimento do Endotélio Vascular , Injeções Intravítreas , Glaucoma/diagnóstico , Tomografia de Coerência Óptica/métodos , Degeneração Macular/tratamento farmacológico , Degeneração Macular Exsudativa/diagnóstico , Degeneração Macular Exsudativa/tratamento farmacológico , Degeneração Macular Exsudativa/epidemiologia , Ranibizumab/uso terapêuticoRESUMO
BACKGROUND: The description of the skin reactions produced by the different vaccines against SARS-CoV-2 has focused on the symptoms reported by the general population. There are few studies with very different measurement methods focused on healthcare workers. METHODS: A longitudinal observational study was conducted on all the healthcare workers from the Hospital Universitario San Cecilio that received vaccination against COVID-19 with BNT162b2. The recruitment period was from December 2020 to September 2021. The recommended regimen was double, with a minimum interval of 21 days between doses. All dermatological reactions reported as adverse effects of the vaccine were evaluated by the Staff of the Dermatology Unit of our center. RESULTS: A total of 3969 healthcare workers of our center were followed. Only 0.7% of them reported dermatological adverse reactions. The most frequently reported reactions were morbilliform rash and COVID arm. In the multivariate analysis, the vaccination regimen (one dose) and the history of COVID-19 infection remained the main factors associated with the report of dermatological adverse reactions. CONCLUSION: The rate of dermatological adverse reactions after vaccination with BNT162b2 (Pfizer-BioNTech) is extraordinarily low. No patient required hospitalization, which supports the safety of this vaccination in a population of healthcare workers.
Assuntos
COVID-19 , Vacinas , Vacina BNT162 , COVID-19/prevenção & controle , Vacinas contra COVID-19/efeitos adversos , Pessoal de Saúde , Humanos , SARS-CoV-2 , Vacinação/efeitos adversosAssuntos
Proteínas do Capsídeo/genética , Enterovirus Humano A/genética , Genótipo , Paraplegia/epidemiologia , Filogenia , África Ocidental/epidemiologia , Criança , Pré-Escolar , Enterovirus Humano A/classificação , Enterovirus Humano A/isolamento & purificação , Fezes/virologia , Variação Genética , Humanos , Tipagem Molecular , Paraplegia/patologia , Paraplegia/virologiaAssuntos
Túnica Conjuntiva/efeitos dos fármacos , Doenças da Túnica Conjuntiva/induzido quimicamente , Granuloma/induzido quimicamente , Lubrificantes Oftálmicos/efeitos adversos , Resinas Acrílicas/efeitos adversos , Administração Tópica , Adulto , Boratos/efeitos adversos , Túnica Conjuntiva/patologia , Doenças da Túnica Conjuntiva/diagnóstico , Combinação de Medicamentos , Feminino , Glucocorticoides/uso terapêutico , Granuloma/diagnóstico , Humanos , Derivados da Hipromelose/efeitos adversos , Cuidados Intraoperatórios , Masculino , Pessoa de Meia-Idade , Necrose/induzido quimicamente , Ácidos Fosforosos/efeitos adversos , Sorbitol/efeitos adversos , Acuidade Visual/fisiologia , VitrectomiaRESUMO
BACKGROUND: There is no evidence of the need for oxygen supplementation during upper digestive endoscopies under ketamine sedation in children, and the latest recommendations specifically state that it is not mandatory for the procedure. The aim of our study is to assess the incidence of respiratory adverse events during upper digestive endoscopies in children under Ketamine sedation when performed without oxygen supplementation, in accordance with the latest recommendations. METHODS: Eighty-eight children undergoing ketamine sedation for programmed upper digestive endoscopy at our Pediatric Intensive Care Unit were included. Patients needing other sedative agents different from ketamine were excluded. No patients received previous oxygen therapy. Suction equipment, oxygen, a bag-valve-mask, and age-appropriate equipment for advanced airway management were immediately available. The primary outcome measure was the incidence of desaturation episodes (i.e. FiO